Industry Research Reports

Home > Reports > Pharma & Healthcare > Interleukin 17A - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Interleukin 17A - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-16

Pages: 92 Pages

Report ld: 2228403

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Interleukin 17A was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Interleukin 17A was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Interleukin 17A was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Interleukin 17A was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Interleukin 17A include AbbVie Inc, Abeome Corporation, Affibody AB, Cell Medica Limited, Eli Lilly and Company, Johnson & Johnson, Merck KGaA, Novartis AG and Orega Biotech SAS, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Interleukin 17A, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Interleukin 17A by region & country, by Type, and by Application.

The Interleukin 17A market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interleukin 17A.

Market Segmentation

Report Metric
Details
Report Title
Interleukin 17A - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Interleukin 17A Companies Covered
AbbVie Inc, Abeome Corporation, Affibody AB, Cell Medica Limited, Eli Lilly and Company, Johnson & Johnson, Merck KGaA, Novartis AG, Orega Biotech SAS
Global Interleukin 17A Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Interleukin 17A Market, Segment by Type
ABY-035

CNTO-6785

DLX-2882

Others
Global Interleukin 17A Market, Segment by Application
Chronic Pain

Liver Cancer

Kidney Cancer

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Interleukin 17A manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Interleukin 17A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Interleukin 17A in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Interleukin 17A Product Introduction
    1.2 Global Interleukin 17A Market Size Forecast
        1.2.1 Global Interleukin 17A Sales Value (2019-2030)
        1.2.2 Global Interleukin 17A Sales Volume (2019-2030)
        1.2.3 Global Interleukin 17A Sales Price (2019-2030)
    1.3 Interleukin 17A Market Trends & Drivers
        1.3.1 Interleukin 17A Industry Trends
        1.3.2 Interleukin 17A Market Drivers & Opportunity
        1.3.3 Interleukin 17A Market Challenges
        1.3.4 Interleukin 17A Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Interleukin 17A Players Revenue Ranking (2023)
    2.2 Global Interleukin 17A Revenue by Company (2019-2024)
    2.3 Global Interleukin 17A Players Sales Volume Ranking (2023)
    2.4 Global Interleukin 17A Sales Volume by Company Players (2019-2024)
    2.5 Global Interleukin 17A Average Price by Company (2019-2024)
    2.6 Key Manufacturers Interleukin 17A Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Interleukin 17A Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Interleukin 17A
    2.9 Interleukin 17A Market Competitive Analysis
        2.9.1 Interleukin 17A Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Interleukin 17A Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interleukin 17A as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 ABY-035
        3.1.2 CNTO-6785
        3.1.3 DLX-2882
        3.1.4 Others
    3.2 Global Interleukin 17A Sales Value by Type
        3.2.1 Global Interleukin 17A Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Interleukin 17A Sales Value, by Type (2019-2030)
        3.2.3 Global Interleukin 17A Sales Value, by Type (%) (2019-2030)
    3.3 Global Interleukin 17A Sales Volume by Type
        3.3.1 Global Interleukin 17A Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Interleukin 17A Sales Volume, by Type (2019-2030)
        3.3.3 Global Interleukin 17A Sales Volume, by Type (%) (2019-2030)
    3.4 Global Interleukin 17A Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Chronic Pain
        4.1.2 Liver Cancer
        4.1.3 Kidney Cancer
        4.1.4 Others
    4.2 Global Interleukin 17A Sales Value by Application
        4.2.1 Global Interleukin 17A Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Interleukin 17A Sales Value, by Application (2019-2030)
        4.2.3 Global Interleukin 17A Sales Value, by Application (%) (2019-2030)
    4.3 Global Interleukin 17A Sales Volume by Application
        4.3.1 Global Interleukin 17A Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Interleukin 17A Sales Volume, by Application (2019-2030)
        4.3.3 Global Interleukin 17A Sales Volume, by Application (%) (2019-2030)
    4.4 Global Interleukin 17A Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Interleukin 17A Sales Value by Region
        5.1.1 Global Interleukin 17A Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Interleukin 17A Sales Value by Region (2019-2024)
        5.1.3 Global Interleukin 17A Sales Value by Region (2025-2030)
        5.1.4 Global Interleukin 17A Sales Value by Region (%), (2019-2030)
    5.2 Global Interleukin 17A Sales Volume by Region
        5.2.1 Global Interleukin 17A Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Interleukin 17A Sales Volume by Region (2019-2024)
        5.2.3 Global Interleukin 17A Sales Volume by Region (2025-2030)
        5.2.4 Global Interleukin 17A Sales Volume by Region (%), (2019-2030)
    5.3 Global Interleukin 17A Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Interleukin 17A Sales Value, 2019-2030
        5.4.2 North America Interleukin 17A Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Interleukin 17A Sales Value, 2019-2030
        5.5.2 Europe Interleukin 17A Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Interleukin 17A Sales Value, 2019-2030
        5.6.2 Asia Pacific Interleukin 17A Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Interleukin 17A Sales Value, 2019-2030
        5.7.2 South America Interleukin 17A Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Interleukin 17A Sales Value, 2019-2030
        5.8.2 Middle East & Africa Interleukin 17A Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Interleukin 17A Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Interleukin 17A Sales Value
        6.2.1 Key Countries/Regions Interleukin 17A Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Interleukin 17A Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Interleukin 17A Sales Value, 2019-2030
        6.3.2 United States Interleukin 17A Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Interleukin 17A Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Interleukin 17A Sales Value, 2019-2030
        6.4.2 Europe Interleukin 17A Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Interleukin 17A Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Interleukin 17A Sales Value, 2019-2030
        6.5.2 China Interleukin 17A Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Interleukin 17A Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Interleukin 17A Sales Value, 2019-2030
        6.6.2 Japan Interleukin 17A Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Interleukin 17A Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Interleukin 17A Sales Value, 2019-2030
        6.7.2 South Korea Interleukin 17A Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Interleukin 17A Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Interleukin 17A Sales Value, 2019-2030
        6.8.2 Southeast Asia Interleukin 17A Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Interleukin 17A Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Interleukin 17A Sales Value, 2019-2030
        6.9.2 India Interleukin 17A Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Interleukin 17A Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 AbbVie Inc
        7.1.1 AbbVie Inc Company Information
        7.1.2 AbbVie Inc Introduction and Business Overview
        7.1.3 AbbVie Inc Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 AbbVie Inc Interleukin 17A Product Offerings
        7.1.5 AbbVie Inc Recent Development
    7.2 Abeome Corporation
        7.2.1 Abeome Corporation Company Information
        7.2.2 Abeome Corporation Introduction and Business Overview
        7.2.3 Abeome Corporation Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Abeome Corporation Interleukin 17A Product Offerings
        7.2.5 Abeome Corporation Recent Development
    7.3 Affibody AB
        7.3.1 Affibody AB Company Information
        7.3.2 Affibody AB Introduction and Business Overview
        7.3.3 Affibody AB Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Affibody AB Interleukin 17A Product Offerings
        7.3.5 Affibody AB Recent Development
    7.4 Cell Medica Limited
        7.4.1 Cell Medica Limited Company Information
        7.4.2 Cell Medica Limited Introduction and Business Overview
        7.4.3 Cell Medica Limited Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Cell Medica Limited Interleukin 17A Product Offerings
        7.4.5 Cell Medica Limited Recent Development
    7.5 Eli Lilly and Company
        7.5.1 Eli Lilly and Company Company Information
        7.5.2 Eli Lilly and Company Introduction and Business Overview
        7.5.3 Eli Lilly and Company Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Eli Lilly and Company Interleukin 17A Product Offerings
        7.5.5 Eli Lilly and Company Recent Development
    7.6 Johnson & Johnson
        7.6.1 Johnson & Johnson Company Information
        7.6.2 Johnson & Johnson Introduction and Business Overview
        7.6.3 Johnson & Johnson Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Johnson & Johnson Interleukin 17A Product Offerings
        7.6.5 Johnson & Johnson Recent Development
    7.7 Merck KGaA
        7.7.1 Merck KGaA Company Information
        7.7.2 Merck KGaA Introduction and Business Overview
        7.7.3 Merck KGaA Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Merck KGaA Interleukin 17A Product Offerings
        7.7.5 Merck KGaA Recent Development
    7.8 Novartis AG
        7.8.1 Novartis AG Company Information
        7.8.2 Novartis AG Introduction and Business Overview
        7.8.3 Novartis AG Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Novartis AG Interleukin 17A Product Offerings
        7.8.5 Novartis AG Recent Development
    7.9 Orega Biotech SAS
        7.9.1 Orega Biotech SAS Company Information
        7.9.2 Orega Biotech SAS Introduction and Business Overview
        7.9.3 Orega Biotech SAS Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Orega Biotech SAS Interleukin 17A Product Offerings
        7.9.5 Orega Biotech SAS Recent Development

 8 Industry Chain Analysis
    8.1 Interleukin 17A Industrial Chain
    8.2 Interleukin 17A Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Interleukin 17A Sales Model
        8.5.2 Sales Channel
        8.5.3 Interleukin 17A Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Interleukin 17A Market Trends
    Table 2. Interleukin 17A Market Drivers & Opportunity
    Table 3. Interleukin 17A Market Challenges
    Table 4. Interleukin 17A Market Restraints
    Table 5. Global Interleukin 17A Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Interleukin 17A Revenue Market Share by Company (2019-2024)
    Table 7. Global Interleukin 17A Sales Volume by Company (2019-2024) & (K Pcs)
    Table 8. Global Interleukin 17A Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Interleukin 17A Price by Company (2019-2024) & (USD/Pcs)
    Table 10. Key Manufacturers Interleukin 17A Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Interleukin 17A Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Interleukin 17A
    Table 13. Global Interleukin 17A Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interleukin 17A as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Interleukin 17A Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Interleukin 17A Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Interleukin 17A Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Interleukin 17A Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Interleukin 17A Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Interleukin 17A Sales Volume by Type: 2019 VS 2023 VS 2030 (K Pcs)
    Table 22. Global Interleukin 17A Sales Volume by Type (2019-2024) & (K Pcs)
    Table 23. Global Interleukin 17A Sales Volume by Type (2025-2030) & (K Pcs)
    Table 24. Global Interleukin 17A Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Interleukin 17A Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Interleukin 17A Price by Type (2019-2024) & (USD/Pcs)
    Table 27. Global Interleukin 17A Price by Type (2025-2030) & (USD/Pcs)
    Table 28. Global Interleukin 17A Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Interleukin 17A Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Interleukin 17A Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Interleukin 17A Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Interleukin 17A Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Interleukin 17A Sales Volume by Application: 2019 VS 2023 VS 2030 (K Pcs)
    Table 34. Global Interleukin 17A Sales Volume by Application (2019-2024) & (K Pcs)
    Table 35. Global Interleukin 17A Sales Volume by Application (2025-2030) & (K Pcs)
    Table 36. Global Interleukin 17A Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Interleukin 17A Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Interleukin 17A Price by Application (2019-2024) & (USD/Pcs)
    Table 39. Global Interleukin 17A Price by Application (2025-2030) & (USD/Pcs)
    Table 40. Global Interleukin 17A Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Interleukin 17A Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Interleukin 17A Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Interleukin 17A Sales Value by Region (2019-2024) & (%)
    Table 44. Global Interleukin 17A Sales Value by Region (2025-2030) & (%)
    Table 45. Global Interleukin 17A Sales Volume by Region (K Pcs): 2019 VS 2023 VS 2030
    Table 46. Global Interleukin 17A Sales Volume by Region (2019-2024) & (K Pcs)
    Table 47. Global Interleukin 17A Sales Volume by Region (2025-2030) & (K Pcs)
    Table 48. Global Interleukin 17A Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Interleukin 17A Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Interleukin 17A Average Price by Region (2019-2024) & (USD/Pcs)
    Table 51. Global Interleukin 17A Average Price by Region (2025-2030) & (USD/Pcs)
    Table 52. Key Countries/Regions Interleukin 17A Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Interleukin 17A Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Interleukin 17A Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Interleukin 17A Sales Volume, (2019-2024) & (K Pcs)
    Table 56. Key Countries/Regions Interleukin 17A Sales Volume, (2025-2030) & (K Pcs)
    Table 57. AbbVie Inc Company Information
    Table 58. AbbVie Inc Introduction and Business Overview
    Table 59. AbbVie Inc Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 60. AbbVie Inc Interleukin 17A Product Offerings
    Table 61. AbbVie Inc Recent Development
    Table 62. Abeome Corporation Company Information
    Table 63. Abeome Corporation Introduction and Business Overview
    Table 64. Abeome Corporation Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 65. Abeome Corporation Interleukin 17A Product Offerings
    Table 66. Abeome Corporation Recent Development
    Table 67. Affibody AB Company Information
    Table 68. Affibody AB Introduction and Business Overview
    Table 69. Affibody AB Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 70. Affibody AB Interleukin 17A Product Offerings
    Table 71. Affibody AB Recent Development
    Table 72. Cell Medica Limited Company Information
    Table 73. Cell Medica Limited Introduction and Business Overview
    Table 74. Cell Medica Limited Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 75. Cell Medica Limited Interleukin 17A Product Offerings
    Table 76. Cell Medica Limited Recent Development
    Table 77. Eli Lilly and Company Company Information
    Table 78. Eli Lilly and Company Introduction and Business Overview
    Table 79. Eli Lilly and Company Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 80. Eli Lilly and Company Interleukin 17A Product Offerings
    Table 81. Eli Lilly and Company Recent Development
    Table 82. Johnson & Johnson Company Information
    Table 83. Johnson & Johnson Introduction and Business Overview
    Table 84. Johnson & Johnson Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 85. Johnson & Johnson Interleukin 17A Product Offerings
    Table 86. Johnson & Johnson Recent Development
    Table 87. Merck KGaA Company Information
    Table 88. Merck KGaA Introduction and Business Overview
    Table 89. Merck KGaA Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 90. Merck KGaA Interleukin 17A Product Offerings
    Table 91. Merck KGaA Recent Development
    Table 92. Novartis AG Company Information
    Table 93. Novartis AG Introduction and Business Overview
    Table 94. Novartis AG Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 95. Novartis AG Interleukin 17A Product Offerings
    Table 96. Novartis AG Recent Development
    Table 97. Orega Biotech SAS Company Information
    Table 98. Orega Biotech SAS Introduction and Business Overview
    Table 99. Orega Biotech SAS Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 100. Orega Biotech SAS Interleukin 17A Product Offerings
    Table 101. Orega Biotech SAS Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Interleukin 17A Downstream Customers
    Table 105. Interleukin 17A Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Interleukin 17A Product Picture
    Figure 2. Global Interleukin 17A Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Interleukin 17A Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Interleukin 17A Sales Volume (2019-2030) & (K Pcs)
    Figure 5. Global Interleukin 17A Sales Price (2019-2030) & (USD/Pcs)
    Figure 6. Interleukin 17A Report Years Considered
    Figure 7. Global Interleukin 17A Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Interleukin 17A Players Sales Volume Ranking (2023) & (K Pcs)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Interleukin 17A Revenue in 2023
    Figure 10. Interleukin 17A Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. ABY-035 Picture
    Figure 12. CNTO-6785 Picture
    Figure 13. DLX-2882 Picture
    Figure 14. Others Picture
    Figure 15. Global Interleukin 17A Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Interleukin 17A Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Interleukin 17A Sales Volume by Type (2019 VS 2023 VS 2030) & (K Pcs)
    Figure 18. Global Interleukin 17A Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Interleukin 17A Price by Type (2019-2030) & (USD/Pcs)
    Figure 20. Product Picture of Chronic Pain
    Figure 21. Product Picture of Liver Cancer
    Figure 22. Product Picture of Kidney Cancer
    Figure 23. Product Picture of Others
    Figure 24. Global Interleukin 17A Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Interleukin 17A Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Interleukin 17A Sales Volume by Application (2019 VS 2023 VS 2030) & (K Pcs)
    Figure 27. Global Interleukin 17A Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Interleukin 17A Price by Application (2019-2030) & (USD/Pcs)
    Figure 29. North America Interleukin 17A Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Interleukin 17A Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Interleukin 17A Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Interleukin 17A Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Interleukin 17A Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Interleukin 17A Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Interleukin 17A Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Interleukin 17A Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Interleukin 17A Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Interleukin 17A Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Interleukin 17A Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Interleukin 17A Sales Volume (%), (2019-2030)
    Figure 41. United States Interleukin 17A Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Interleukin 17A Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Interleukin 17A Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Interleukin 17A Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Interleukin 17A Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Interleukin 17A Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Interleukin 17A Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Interleukin 17A Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Interleukin 17A Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Interleukin 17A Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Interleukin 17A Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Interleukin 17A Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Interleukin 17A Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Interleukin 17A Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Interleukin 17A Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Interleukin 17A Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Interleukin 17A Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Interleukin 17A Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Interleukin 17A Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Interleukin 17A Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Interleukin 17A Sales Value by Application (%), 2023 VS 2030
    Figure 62. Interleukin 17A Industrial Chain
    Figure 63. Interleukin 17A Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed

Description

The global market for Interleukin 17A was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Interleukin 17A was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Interleukin 17A was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Interleukin 17A was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Interleukin 17A include AbbVie Inc, Abeome Corporation, Affibody AB, Cell Medica Limited, Eli Lilly and Company, Johnson & Johnson, Merck KGaA, Novartis AG and Orega Biotech SAS, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Interleukin 17A, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Interleukin 17A by region & country, by Type, and by Application.

The Interleukin 17A market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interleukin 17A.

Market Segmentation